Volume 17, special issue 4, Volume 17, numéro spécial 4

éditorial

Is serum infliximab becoming a keystone marker of clinical outcome after schedule maintenance treatment for inflammatory bowel disease ? (p.3-7)
Xavier Roblin
Free Access

mini-revue

Azathioprine: optimal duration in IBD patients (p.9-19)
Xavier Roblin, E Del Tedesco
Free Access

How optimize the management of a patient with a severe attack of ulcerative colitis? (p.21-7)
David Laharie
Free Access

Why the anti TNF therapies differe on treatment of IBD patients ? What is the role of IL15/sIL-15Rα ? (p.29-34)
Arnaud Bourreille
Free Access

Colonic dysplasia in IBD : management in 2010 (p.35-42)
Driffa Moussata, Gilles Boschetti, Eddy Cotte, Stéphane Nancey, Françoise Berger, Bernard Flourié
Free Access

Management of perianal Crohn's disease in 2010 (p.43-52)
Jérôme Filippi, Amine Rahili, Jenny Vibert, Xavier Hébuterne
Free Access

How to manage postoperative recurrence in Crohn's disease in 2010? (p.53-9)
Camille Zallot, Laurent Peyrin-Biroulet
Free Access